FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298325631> ?p ?o ?g. }

• W4298325631 endingPage "100760" @default.
• W4298325631 startingPage "100760" @default.
• W4298325631 abstract "Since the outbreak of the COVID-19 pandemic, some studies have reported an increased preeclampsia incidence in pregnant women with SARS-CoV-2 infection. Several explanations for this association have been proposed, including a preeclampsia-like syndrome induced by severe COVID-19. This syndrome was described in a small case series and has not been confirmed in larger studies, and its effect on perinatal outcomes has not been studied.This study aimed to confirm the preeclampsia-like syndrome because of COVID-19 and to investigate its implications on pregnancy outcomes and prognosis.This was a prospective, observational study conducted in a tertiary referral hospital. The inclusion criteria were pregnant women admitted to the intensive care unit for severe pneumonia because of COVID-19. They were classified into 3 groups based on clinical and laboratory findings: preeclampsia, preeclampsia-like syndrome, and women without preeclampsia features. The 3 cohorts were analyzed and compared at 3 different times: before, during, and after severe pneumonia. The main outcomes were incidence of adverse perinatal outcomes and signs and symptoms of PE, such as hypertension, proteinuria, thrombocytopenia, elevated liver enzymes, and increased angiogenic factors (soluble fms-like tyrosine kinase 1-to-placental growth factor ratio).A total of 106 women were admitted to the intensive care unit because of severe pneumonia, and 68 women were included in the study. Of those, 53 (50.0%) did not meet the diagnostic criteria for preeclampsia and remained pregnant after pneumonia (non-preeclampsia); 7 (6.6%) met the diagnostic criteria for preeclampsia, had abnormal (>38) soluble fms-like tyrosine kinase 1-to-placental growth factor ratio (preeclampsia), and delivered during severe pneumonia, and 8 (7.5%) met the diagnostic criteria for preeclampsia, had normal (≤38) soluble fms-like tyrosine kinase 1-to-placental growth factor ratio (preeclampsia like), and did not deliver during pneumonia. Despite not having delivered, most preeclampsia-related features improved after severe pneumonia in women with preeclampsia-like syndrome. Women with preeclampsia had significantly poorer outcomes than women with preeclampsia-like syndrome or without preeclampsia.More than 50% of women with severe COVID-19 and diagnostic criteria for preeclampsia may not be preeclampsia but a preeclampsia-like syndrome, which may affect up to 7.5% of women with severe COVID-19. Preeclampsia-like syndrome might have similar perinatal outcomes to those of normotensive women with severe pneumonia because of COVID-19. For these reasons, preeclampsia-like syndrome should be excluded by using soluble fms-like tyrosine kinase 1-to-placental growth factor ratio in future research and before making clinical decisions." @default.
• W4298325631 created "2022-10-02" @default.
• W4298325631 creator A5004845966 @default.
• W4298325631 creator A5005692303 @default.
• W4298325631 creator A5006411072 @default.
• W4298325631 creator A5010370605 @default.
• W4298325631 creator A5013345099 @default.
• W4298325631 creator A5018838637 @default.
• W4298325631 creator A5040759671 @default.
• W4298325631 creator A5042941884 @default.
• W4298325631 creator A5052480929 @default.
• W4298325631 creator A5070140819 @default.
• W4298325631 creator A5071397558 @default.
• W4298325631 creator A5077465774 @default.
• W4298325631 creator A5080618772 @default.
• W4298325631 creator A5088921346 @default.
• W4298325631 date "2023-01-01" @default.
• W4298325631 modified "2023-10-16" @default.
• W4298325631 title "Confirmation of preeclampsia-like syndrome induced by severe COVID-19: an observational study" @default.
• W4298325631 cites W1904070962 @default.
• W4298325631 cites W1977585707 @default.
• W4298325631 cites W2008931114 @default.
• W4298325631 cites W2019033274 @default.
• W4298325631 cites W2026146676 @default.
• W4298325631 cites W2029432061 @default.
• W4298325631 cites W2062983847 @default.
• W4298325631 cites W2065594976 @default.
• W4298325631 cites W2080542014 @default.
• W4298325631 cites W2162306390 @default.
• W4298325631 cites W2904516565 @default.
• W4298325631 cites W3012611938 @default.
• W4298325631 cites W301622561 @default.
• W4298325631 cites W3016592723 @default.
• W4298325631 cites W3032478816 @default.
• W4298325631 cites W3153280783 @default.
• W4298325631 cites W3174033175 @default.
• W4298325631 cites W3186876630 @default.
• W4298325631 cites W3199715548 @default.
• W4298325631 cites W3201995458 @default.
• W4298325631 cites W3212864805 @default.
• W4298325631 cites W4213172203 @default.
• W4298325631 cites W4280491857 @default.
• W4298325631 doi "https://doi.org/10.1016/j.ajogmf.2022.100760" @default.
• W4298325631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36195282" @default.
• W4298325631 hasPublicationYear "2023" @default.
• W4298325631 type Work @default.
• W4298325631 citedByCount "5" @default.
• W4298325631 countsByYear W42983256312023 @default.
• W4298325631 crossrefType "journal-article" @default.
• W4298325631 hasAuthorship W4298325631A5004845966 @default.
• W4298325631 hasAuthorship W4298325631A5005692303 @default.
• W4298325631 hasAuthorship W4298325631A5006411072 @default.
• W4298325631 hasAuthorship W4298325631A5010370605 @default.
• W4298325631 hasAuthorship W4298325631A5013345099 @default.
• W4298325631 hasAuthorship W4298325631A5018838637 @default.
• W4298325631 hasAuthorship W4298325631A5040759671 @default.
• W4298325631 hasAuthorship W4298325631A5042941884 @default.
• W4298325631 hasAuthorship W4298325631A5052480929 @default.
• W4298325631 hasAuthorship W4298325631A5070140819 @default.
• W4298325631 hasAuthorship W4298325631A5071397558 @default.
• W4298325631 hasAuthorship W4298325631A5077465774 @default.
• W4298325631 hasAuthorship W4298325631A5080618772 @default.
• W4298325631 hasAuthorship W4298325631A5088921346 @default.
• W4298325631 hasBestOaLocation W42983256311 @default.
• W4298325631 hasConcept C120665830 @default.
• W4298325631 hasConcept C121332964 @default.
• W4298325631 hasConcept C126322002 @default.
• W4298325631 hasConcept C131872663 @default.
• W4298325631 hasConcept C187212893 @default.
• W4298325631 hasConcept C188816634 @default.
• W4298325631 hasConcept C23131810 @default.
• W4298325631 hasConcept C2776376669 @default.
• W4298325631 hasConcept C2777218350 @default.
• W4298325631 hasConcept C2777914695 @default.
• W4298325631 hasConcept C2779234561 @default.
• W4298325631 hasConcept C2779561371 @default.
• W4298325631 hasConcept C2780091579 @default.
• W4298325631 hasConcept C54355233 @default.
• W4298325631 hasConcept C61511704 @default.
• W4298325631 hasConcept C71924100 @default.
• W4298325631 hasConcept C86803240 @default.
• W4298325631 hasConceptScore W4298325631C120665830 @default.
• W4298325631 hasConceptScore W4298325631C121332964 @default.
• W4298325631 hasConceptScore W4298325631C126322002 @default.
• W4298325631 hasConceptScore W4298325631C131872663 @default.
• W4298325631 hasConceptScore W4298325631C187212893 @default.
• W4298325631 hasConceptScore W4298325631C188816634 @default.
• W4298325631 hasConceptScore W4298325631C23131810 @default.
• W4298325631 hasConceptScore W4298325631C2776376669 @default.
• W4298325631 hasConceptScore W4298325631C2777218350 @default.
• W4298325631 hasConceptScore W4298325631C2777914695 @default.
• W4298325631 hasConceptScore W4298325631C2779234561 @default.
• W4298325631 hasConceptScore W4298325631C2779561371 @default.
• W4298325631 hasConceptScore W4298325631C2780091579 @default.
• W4298325631 hasConceptScore W4298325631C54355233 @default.
• W4298325631 hasConceptScore W4298325631C61511704 @default.
• W4298325631 hasConceptScore W4298325631C71924100 @default.
• W4298325631 hasConceptScore W4298325631C86803240 @default.

• next